VIVOS THERAPEUTICS INC's ticker is VVOS and the CUSIP is 92859E108. A total of 28 filers reported holding VIVOS THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $0 | -100.0% | 439 | -67.2% | 0.00% | – |
| Q2 2023 | $1,000 | – | 1,339 | +303.3% | 0.00% | – |
| Q1 2023 | $0 | – | 332 | +232.0% | 0.00% | – |
| Q4 2022 | $0 | -100.0% | 100 | -99.4% | 0.00% | – |
| Q3 2022 | $11,000 | – | 17,165 | +7022.4% | 0.00% | – |
| Q2 2022 | $0 | – | 241 | +70.9% | 0.00% | – |
| Q1 2022 | $0 | – | 141 | 0.0% | 0.00% | – |
| Q4 2021 | $0 | -100.0% | 141 | -79.2% | 0.00% | – |
| Q3 2021 | $3,000 | – | 678 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| PERKINS CAPITAL MANAGEMENT INC | 162,500 | $804,000 | 0.46% |
| BARD ASSOCIATES INC | 215,500 | $1,067,000 | 0.35% |
| Millrace Asset Group, Inc. | 93,993 | $465,000 | 0.24% |
| Archon Capital Management LLC | 215,000 | $1,064,000 | 0.12% |
| Penn Capital Management Company, LLC | 223,403 | $1,106,000 | 0.11% |
| GRIFFIN ASSET MANAGEMENT, INC. | 49,500 | $245,000 | 0.03% |
| K2 PRINCIPAL FUND, L.P. | 64,746 | $320,000 | 0.03% |
| Walleye Capital LLC | 150,000 | $743,000 | 0.02% |
| WMS Partners, LLC | 16,667 | $153,000 | 0.02% |
| Avalon Investment & Advisory | 189,739 | $939,000 | 0.02% |